https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html

The global genotyping market is expected to reach $17.0 billion in 2020 from $6.2 billion in 2015, at a CAGR of 22.3% during the forecast period of 2015 to 2020. Market growth will be attributed to the availability of a range of products for wide applications, decreasing prices of DNA sequencing, increasing incidence of and awareness on genetic diseases and personalized medicine, increasing demand for pharmacogenomics in drug discovery and development, and the rising use of genetic analysis of animal and plant livestock.

The genotyping market studied in this report is mainly segmented by product, technology, applications, and end user. The market, by product, is segmented into instruments (sequencers & amplifiers, and analyzers), reagents and kits, bioinformatics software and genotyping services. Reagents & kits market is expected to see high growth during the forecast period owing to its increasing demand & applications in pharmacogenomics for drug efficacy and safety, personalized medicine for the treatment for chronic diseases, for genome analysis of animals & plants.

Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The high growth in this segment is attributed to increasing use of genotyping in drug development process & to analyze the effects of drug.

The market, by technology, is segmented into microarray, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, and others (allele specific oligonucleotide (ASO) probes & in situ hybridization). Sequencing market is forecasted to see a significant growth of CAGR 27.7% over the forecast period, owing to its widening application areas of DNA sequencing technologies, technological advancements, and the availability of high-speed sequencing instruments are expected to contribute to the growth of the DNA sequencing market in the coming years.

Developed geographies like North America and Europe are saturated markets and expected to grow at a slower rate, whereas the Asian-Pacific market is expected to witness the highest growth of 25.4% CAGR during the forecast period, due to the huge demand for better healthcare services, expanding per capita income, increasing ongoing clinical trials in these regions, and the increasing focus of leading players on these regions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=249958595

The key players operating in this market are Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=249958595

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Shelly Singh
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]